TY - JOUR
T1 - Cardiac progression of systemic light chain amyloidosis
AU - Azanza, Diego Xavier Chango
AU - Tirado, Ruth Lizbeth Fernández
AU - Pillaga, Valeria Verenisse López
AU - Ochoa, José David Tello
AU - Vásquez, Javier Fernando Pinos
N1 - Publisher Copyright:
© 2022, National Cardiovascular Institute - INCOR. All rights reserved.
PY - 2022/12/31
Y1 - 2022/12/31
N2 - Systemic light chain amyloidosis is a disease characterized by the accumulation of amyloid protein in multiple organs and systems. We present the case of a 52-year-old male patient with a diagnosis of systemic light chain amyloidosis associated with cardiac and renal involvement. A renal biopsy showed the presence of renal amyloidosis associated with proteinuria, and the patient was referred for cardiovascular evaluation. The baseline electrocardiogram (ECG) showed microvoltage in frontal leads that were discordant with the left ventricular hypertrophy evidenced in the transthoracic echocardiogram (TTE). Cardiac magnetic resonance confirmed the presence of cardiac amyloid infiltration with a pattern of extensive ventricular late gadolinium enhancement. Despite being referred and receiving specific systemic chemotherapy treatment, the evolution was not favorable after four months of follow-up with worsening cardiac infiltration, increasing values of biomarkers and progression of dyspnea. The TTE was useful in revealing the unfavorable evolution and worsening of diastolic function parameters and increased wall thickness in the context of infiltration. The ECG and TTE were easily accessible tools that allowed the monitoring of the response to treatment.
AB - Systemic light chain amyloidosis is a disease characterized by the accumulation of amyloid protein in multiple organs and systems. We present the case of a 52-year-old male patient with a diagnosis of systemic light chain amyloidosis associated with cardiac and renal involvement. A renal biopsy showed the presence of renal amyloidosis associated with proteinuria, and the patient was referred for cardiovascular evaluation. The baseline electrocardiogram (ECG) showed microvoltage in frontal leads that were discordant with the left ventricular hypertrophy evidenced in the transthoracic echocardiogram (TTE). Cardiac magnetic resonance confirmed the presence of cardiac amyloid infiltration with a pattern of extensive ventricular late gadolinium enhancement. Despite being referred and receiving specific systemic chemotherapy treatment, the evolution was not favorable after four months of follow-up with worsening cardiac infiltration, increasing values of biomarkers and progression of dyspnea. The TTE was useful in revealing the unfavorable evolution and worsening of diastolic function parameters and increased wall thickness in the context of infiltration. The ECG and TTE were easily accessible tools that allowed the monitoring of the response to treatment.
KW - Cardiomyopathies
KW - Echocardiography. (Source: MeSH-NLM)
KW - Electrocardiography
KW - Heart Failure
KW - Inmunoglobulin Light-chain Amyloidosis
UR - https://upcommons.upc.edu/handle/2117/100231
U2 - 10.47487/apcyccv.v3i4.249
DO - 10.47487/apcyccv.v3i4.249
M3 - Artículo
AN - SCOPUS:85185149051
SN - 2708-7212
VL - 3
SP - 220
EP - 225
JO - Archivos Peruanos de Cardiologia y Cirugia Cardiovascular
JF - Archivos Peruanos de Cardiologia y Cirugia Cardiovascular
IS - 4
ER -